Ignite Creation Date:
2024-05-05 @ 5:15 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00416741
Status:
COMPLETED
Last Update Posted:
2011-06-27
First Post:
2006-12-27
Brief Title:
Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes ATTEMPT
Sponsor:
Hellenic Atherosclerosis Society
Organization:
Hellenic Atherosclerosis Society
Study Overview
Official Title:
Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes ATTEMPT
Status:
COMPLETED
Status Verified Date:
2011-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ATTEMPT
Brief Summary:
The objective of this protocol is to improve awareness treatment and control of metabolic syndrome within primary prevention of cardiovascular disease by implementing guidelines after training of the participating physicians
Detailed Description:
Physicians from 20 hospitals or health centres primary and secondary health care settings were trained to implement guidelines in treating metabolic syndrome
There will be a baseline recording of patients with metabolic syndrome and then physicians will have to complete a one page form by ticking pre-specified boxes about the baseline status of the patients and will have to report the measures they took to improve awareness treatment and effective control of the metabolic syndrome With 6 month intervals up to 36 months at study completion physicians will have to complete the same form Previous training of physicians and the fact that they will have to report their success in treating metabolic syndrome will hopefully contribute to an increase in number of patients with the syndrome at treatment targets and will minimise the target organ damage ie cardiovascular disease The estimated 10-year reduction in coronary heart disease risk will be evaluated by a comparison of this risk as evaluated by a risk engine ie PROCAM at the 6th month and at study completion with that of baseline
There will be a baseline recording of patients with metabolic syndrome and then physicians will have to complete a one page form by ticking pre-specified boxes about the baseline status of the patients and will have to report the measures they took to improve awareness treatment and effective control of the metabolic syndrome With 6 month intervals up to 36 months at study completion physicians will have to complete the same form Previous training of physicians and the fact that they will have to report their success in treating metabolic syndrome will hopefully contribute to an increase in number of patients with the syndrome at treatment targets and will minimise the target organ damage ie cardiovascular disease The estimated 10-year reduction in coronary heart disease risk will be evaluated by a comparison of this risk as evaluated by a risk engine ie PROCAM at the 6th month and at study completion with that of baseline
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None